US 12331297
Coagulation factor V (F5) iRNA compositions and methods of use thereof
granted A61KA61K45/06A61K47/549
Quick answer
US patent 12331297 (Coagulation factor V (F5) iRNA compositions and methods of use thereof) held by Alnylam Pharmaceuticals, Inc. expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue Jun 17 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K45/06, A61K47/549, A61K9/0019, A61P